The rapid utilization of single-use disposables to prevent contamination in the healthcare environment is driving the global single-use technology for biopharmaceuticals market, says Fortune Business Insights in a report, titled “Single-use Technology for Biopharmaceuticals Market Size, Share and Global Trend By Product Type (Equipment, Consumables), By End-user (Biopharmaceutical Manufacturer, Academic Clinical Research Institutes, Others) and Geography Forecast till 2026.” Rising need for upstream and downstream purification during manufacturing is a factor promoting the global single-use technology for biopharmaceuticals market.
Get Sample PDF [email protected]
Launch of New Single-Use Technologies by Milliporesigma Will Encourage Growth
Milliporesigman, a global life science company announced three new products designed to make single-use bioprocessing safer, easier, and more efficient. The launch of Pellicon capsule, Millipak final fill filter and Mobius Power MIX 2500-liter and 3000-liter are likely to aid the global single-use technology for biopharmaceuticals growth owing to the bioprocessing innovation in the new superior single-use technologies.
The award won by the Milliporesigman for best technological innovation at INTERPHEX 2018 will have also have a progressive impact on the market. Furthermore, the launch of Single-Use Chromatography System is also expected to contribute to the global single-use technology for biopharmaceuticals revenue. For instance, Pall Corporation. launched Allegro Single-Use Chromatography System that can be used in a flow range of 10 to 900 L/h.
Browse Complete Report Details @
By Product Type
- Biopharmaceutical Manufacturer
- Academic & Clinical Research Institutes
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Some of the Main Key Players Covered in the Report
- Electric Company
- Aber Instruments Ltd
- Kühner AG
- Robert Bosch Packaging Technology GmbH
- Hamilton Medical
- Merck KgaA
- Terumo Corporation
- GEMÜ Gruppe
- Infors AG
New Product Launches Will Boost Growth in North America
Geographically, the global single-use technology for biopharmaceuticals market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa. The single-use technology for biopharmaceuticals market in North America and Europe is predicted to grow at a faster pace during the forecast period owing to the frequent new pharmaceutical product launches.
The increasing trend of strategic planning, as well as research collaborations in pharmaceutical industries, is also predicted to aid growth in the above regions. Additionally, the stringent regulatory guidelines for bioprocessing is anticipated to increase the adoption of single-use technologies in Europe and North America. Asia Pacific is expected to grow at a considerable rate owing to the presence of various upcoming pharmaceutical production plants and rapid acceptance of the use of single-use disposables.
More Trending Topics from Fortune Business Insights: